
Drs. Crawford and Hou provide an important clinical introduction to a novel class of hormonal agents that have been under development for several decades for the treatment of advanced and metastatic prostate cancer.
Your AI-Trained Oncology Knowledge Connection!
Published: June 9th 2009 | Updated: